Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats

Context Therapeutic doxorubicin administration is restricted as this anticancer drug may be cardiotoxic. The traditional Chinese medicine qiliqiangxin has been approved for clinical treatment of chronic heart failure. Objective To explore the protective effects and molecular mechanisms of qiliqiangx...

Full description

Bibliographic Details

Published in:	Pharmaceutical Biology
Main Authors:	Xutao Sun, Guozhen Chen, Ying Xie, Deyou Jiang, Jieru Han, Fei Chen, Yunjia Song
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Subjects:	chronic heart failure mirnas tgf-β1/smad3 tgf-β3/smad7
Online Access:	http://dx.doi.org/10.1080/13880209.2020.1761403